Single-cell sequencing methods have enabled multi-modal characterization of tumor heterogeneity and yielded novel insights into tumor evolution, therapeutic response and resistance, and measurable residual disease (MRD). Hear from our Field Application Scientist, Dr. Gema Fuerte, as she shares with a live audience from Europe how the Tapestri Platform works and showcases the novel capability to co-detect SNVs, CNVs, and immunophenotype from the same cell with a single high-throughput workflow.
